Open AccessPoverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma
Author(s) -
Kira Bona,
Yimei Li,
Lena E. Winestone,
Kelly Getz,
YuanShung Huang,
Brian T. Fisher,
Ami Desai,
Troy Richardson,
Matt Hall,
Arlene Naranjo,
Tara O. Henderson,
Richard Aplenc,
Rochelle Bagatell
Publication year - 2020
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djaa107
Subject(s) - medicine , poverty , hazard ratio , context (archaeology) , quartile , cohort , proportional hazards model , demography , household income , confidence interval , oncology , biology , paleontology , sociology , economics , economic growth , history , archaeology
Whether social determinants of health are associated with survival in the context of pediatric oncology-targeted immunotherapy trials is not known. We examined the association between poverty and event-free survival (EFS) and overall survival (OS) for children with high-risk neuroblastoma treated in targeted immunotherapy trials.